ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
86 announcements with these filters
Clean headline: revenue +16% YoY, EBITDA 34%, PAT +14%. Growth leans on deferred sales and rising top-10 customer concentration (46%). US recovery is only hoped for.
Advanced Enzyme Technologies applied to exchanges to reclassify 13 promoter group members as public under Regulation 31A. They hold 59,000 shares combined, about 0.05%.
Q2 FY27 consolidated revenue ₹2,145mn (+16% YoY), EBITDA ₹721mn (+20%, 34% margin), PAT ₹512mn (+14%). H1 revenue +10%, PAT +5%. Industrial bio-processing and animal nutrition lead growth.
Advanced Enzyme Technologies issued a press release highlighting unaudited Q2 and half-year FY27 results. Revenue and profit grew year-on-year, with EBITDA and PAT margins reported.
Advanced Enzyme Technologies Ltd reported revenue from operations of ₹214.5 Cr (+16.3% YoY) and net profit of ₹51.2 Cr (+14.5% YoY) for Q2 FY27.
Advanced Enzyme closed its buyback after purchasing 2,410,906 shares for ₹69.70 Crore. Closure took effect October 30, 2026, ahead of the scheduled period.
Advanced Enzyme Technologies bought back 54,455 equity shares via Emkay Global on October 29, 2026 at an average of ₹263.76. Cumulative buyback stands at 24,10,906 shares under the ongoing open-market programme.
Advanced Enzyme bought back 64,583 shares on 28-10-2026 at an average ₹262.49, totalling 23,56,451 shares to date. Purchases were made via Emkay Global on the open market.
Advanced Enzyme bought back 29,115 shares on October 27, 2026, worth about ₹0.75 Crore. Cumulative buyback stands at 22,91,868 shares under its open-market programme.
Advanced Enzyme Technologies will hold a board meeting on 31 October 2026 to approve Q2 and H1 FY27 unaudited results. The trading window stays closed until 2 November 2026.
Advanced Enzyme Technologies bought back 58,326 equity shares at an average price of ₹263.3605 per share on October 22, 2026.
Advanced Enzyme Technologies Ltd. received a request from Snehal Shamsunder Soni to reclassify their shareholding from the 'Promoter Group' to the 'Public' category.
Advanced Enzyme Technologies reported the daily buyback of 55,794 shares from the open market at an average price of Rs. 267.5974 per share.
Advanced Enzyme Technologies Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required by SEBI regulations.
Advanced Enzyme Technologies bought back 40,000 shares on October 14, 2026, at an average price of ₹268.00 per share, totaling approximately ₹1.07 Crore.
Advanced Enzyme Technologies bought back 26,000 equity shares at an average price of ₹269.38 per share, totaling ₹0.70 Crore.
Advanced Enzyme Technologies received requests from promoter group members Sunil Ramdayal Attal and Megha Jhawar to reclassify their shareholding from 'Promoter Group' to 'Public' category.
Advanced Enzyme Technologies bought back 46,158 equity shares on October 09, 2026, at an average price of ₹269.02 per share.
Advanced Enzyme Technologies filed a daily report for its ongoing buyback program. No shares were bought back on October 08, 2026.
Advanced Enzyme Technologies Ltd bought back 26,000 shares at an average price of ₹276.1955 on October 06, 2026, totaling approximately ₹0.72 Crore.
Advanced Enzyme Technologies bought back 30,000 shares today at an average price of ₹274.96. This daily report confirms shares acquired under the company's buyback program.
Advanced Enzyme Technologies bought back 25,000 equity shares at an average price of ₹285.61 on September 30, 2026, as part of its ongoing buyback program.
Advanced Enzyme Technologies received a request from Radhika Ashish Pujara to reclassify her status from 'Promoter Group' to 'Public' shareholder.
Advanced Enzyme Technologies Ltd bought back 25,000 equity shares at an average price of ₹288.41 per share, totalling ₹0.72 Crore, under its ongoing buyback programme.
Advanced Enzyme Technologies Ltd bought back 50,000 equity shares on September 25, 2026. This transaction was executed at an average price of ₹295.80 per share.
Advanced Enzyme Technologies bought back 64,668 shares on September 24, 2026, at an average price of ₹298.0272 per share.
Advanced Enzyme Technologies bought back 63,616 shares at an average price of ₹297.47. The total value of today's buyback transaction is ₹1.89 Crore.
Advanced Enzyme Technologies Ltd repurchased 1,136 equity shares on September 22, 2026, at an average price of ₹295.90. This daily filing is for compliance.
Advanced Enzyme Technologies bought back 50,000 equity shares on September 21, 2026, at an average price of ₹289.49 per share.
Advanced Enzyme Technologies received requests from four promoter group members to reclassify as 'Public' shareholders. These requests are pending board consideration.